← Leaderboards
Susan Napier Thomas
Georgia Institute Of Technology
$4,309,850
Attributed
$6,589,152
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,589,152 · 6
By mechanism
R01$5,969,819 · 3
R21$600,333 · 1
R13$19,000 · 2
Top collaborators
- M.G. Finn6 shared
- James Brandon Dixon3 shared
- Andres J Garcia3 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Gabriel A Kwong$15,355,526
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTechnologyTissuesDesignImmuneAnimalsInnovationLymph NodesPharmaceutical PreparationsIn VivoMouse ModelDrug TargetingInsightDrug Delivery SystemsDrug FormulationsTumorImmunotherapySynergismNanoparticleB-LymphocytesLymphocyteEnsureImmunotherapeutic AgentFormulation
Grant awards (22)
Lymphedema therapy via lymphatic targeted drug delivery$610,690
R01 · FY2025 · HL · contact PI
Lymphedema therapy via lymphatic targeted drug delivery$664,892
R01 · FY2024 · HL · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$456,887
R01 · FY2024 · CA · contact PI
LYMPHEDEMA THERAPY VIA LYMPHATIC TARGETED DRUG DELIVERY$46,520
R01 · FY2024 · HL · contact PI
2024 Immunoengineering Gordon Research Conference & Gordon Research Seminar$9,000
R13 · FY2024 · AI · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$548,563
R01 · FY2023 · CA · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$491,199
R01 · FY2022 · CA · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$82,825
R01 · FY2022 · CA · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$514,622
R01 · FY2021 · CA · contact PI
Lymph node-targeted multistage chemoimmunotherapy for lymphoma$542,074
R01 · FY2020 · CA · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$359,568
R01 · FY2020 · CA · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$348,780
R01 · FY2019 · CA · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$68,601
R01 · FY2019 · CA · contact PI
Regenerative Medicine Workshop at Charleston 2019$10,000
R13 · FY2019 · EB · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$359,568
R01 · FY2018 · CA · contact PI
uSHEAR Technology for Cancer Cell Purificaiton$225,649
R21 · FY2018 · CA
Melanoma immunotherapy targeting sentinel lymph nodes$70,722
R01 · FY2018 · CA · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$359,568
R01 · FY2017 · CA · contact PI
uSHEAR Technology for Cancer Cell Purificaiton$187,017
R21 · FY2017 · CA
Melanoma immunotherapy targeting sentinel lymph nodes$70,722
R01 · FY2017 · CA · contact PI
Melanoma immunotherapy targeting sentinel lymph nodes$374,018
R01 · FY2016 · CA · contact PI
uSHEAR Technology for Cancer Cell Purificaiton$187,667
R21 · FY2016 · CA